Misplaced Pages

This is an old revision of this page, as edited by JJMC89 bot (talk | contribs) at 00:25, 14 December 2024 (Add {{drafts moved from mainspace}}). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages) This article relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources. Find sources: "Bias Capital" – news · newspapers · books · scholar · JSTOR (December 2024) (Learn how and when to remove this message)

Bias Capital is an American venture capital firm that invests in startups across a wide range of industries, with a focus on incubation, early-stage and growth companies.

The firm was established to integrate diversity as a core principle in its investment strategy and operations. Rather than treating diversity as a separate initiative, Bias Capital incorporates it into all aspects of its decision-making process.

The firm aims to build a portfolio that reflects societal diversity by supporting underrepresented founders and fostering inclusive innovation.

Bias Capital operates as the venture capital arm of PasciVite.

Notable Investments

In July 2023, Bias Capital led a $25 million Series A funding round for Parker Health, a biotech company focused on revolutionizing electronic health records and healthcare management.

1. "Parker Health Secures $25 Million in Series A Funding to Transform American Healthcare". Archived from the original on 2024-10-05. Retrieved 2024-12-13.